How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer

BACKGROUND: Germline BRCA1 and BRCA2 mutation testing offered shortly after a breast cancer diagnosis to inform women’s treatment choices - treatment-focused genetic testing ‘TFGT’ - has entered clinical practice in specialist centers and is likely to be soon commonplace in acute breast cancer manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Watts, Kaaren J, Meiser, Bettina, Mitchell, Gillian, Kirk, Judy, Saunders, Christobel, Peate, Michelle, Duffy, Jessica, Kelly, Patrick J, Gleeson, Margaret, Barlow-Stewart, Kristine, Rahman, Belinda, Friedlander, Michael, Tucker, Kathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472271/
https://www.ncbi.nlm.nih.gov/pubmed/22838957
http://dx.doi.org/10.1186/1471-2407-12-320

Ejemplares similares

Ejemplares similares